Lack of In Vivo Correlation Between Indinavir and Saquinavir Exposure and Cytochrome P450 3A Phenotype as Assessed with Oral Midazolam as a Phenotype Probe
Effect of Food and Ranitidine on Saquinavir Pharmacokinetics and Gastric pH in Healthy Volunteers
Factors Affecting the Apparent Clearance of Tacrolimus in Korean Adult Liver Transplant Recipients
Outcomes Associated with Vasoactive Therapy in Patients with Acute Decompensated Heart Failure
Prophylaxis Against Venous Thromboembolism in Acutely Ill Medical Patients: An Observational Study
Reversal of Elevated International Normalized Ratios and Bleeding with Low-Dose Recombinant Activated Factor VII in Patients Receiving Warfarin
Tigecycline: First of a New Class of Antimicrobial Agents
An Update and Review of Antiretroviral Therapy
Long-term Use of Atypical Antipsychotics in Bipolar Disorder
Clinical Effects and Management of Methamphetamine Abuse
Drug Copayment and Adherence in Chronic Heart Failure: Effect on Cost and Outcomes
Golf-Inhibiting Gynecomastia Associated with Atorvastatin Therapy
Cefepime Neurotoxicity: Case Report, Pharmacokinetic Considerations, and Literature Review
Atypical Warfarin-Induced Skin Necrosis
Olanzapine-Associated Neuroleptic Malignant Syndrome
Bell's Palsy Associated with Linezolid Therapy: Case Report and Review of Neuropathic Adverse Events
Short-Term Memory Loss Associated with Rosuvastatin
Utilization of the Center for the Advancement of Pharmaceutical Education Educational Outcomes , Revised Version 2004: Report of the 2005 American College of Clinical Pharmacy Educational Affairs Committee
Antiplatelet Drug Resistance: Almost Ready for Prime Time
Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients with New York Heart Association Class II-IV Symptoms
Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients with New York Heart Association Class II-IV Symptoms
Tumor Lysis Syndrome Early After Treatment with Bortezomib for Multiple Myeloma
Tumor Lysis Syndrome Early After Treatment with Bortezomib for Multiple Myeloma